Subsequently, the capacity of five selected DARPin TCEs to elicit wild-type NY-ESO1157-165 (9C)-specific activation of CD8+ T cells was evaluated by co-incubating T cells and each TCE with HLA-A∗0201+ tumor cell lines expressing NY-ESO1157-165 (9C) (Figure 1E). This evidence concerns the gene CD8A and neoplasm.